BioSenic S.A. (BIOS.BR)

EUR 0.01

(-5.71%)

Total Liabilities Summary of BioSenic S.A.

  • BioSenic S.A.'s latest annual total liabilities in 2023 was 32.26 Million EUR , up 23.15% from previous year.
  • BioSenic S.A.'s latest quarterly total liabilities in 2024 Q1 was 29.8 Million EUR , down -7.64% from previous quarter.
  • BioSenic S.A. reported annual total liabilities of 26.2 Million EUR in 2022, down -1.27% from previous year.
  • BioSenic S.A. reported annual total liabilities of 26.53 Million EUR in 2021, up 23.37% from previous year.
  • BioSenic S.A. reported quarterly total liabilities of 29.8 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • BioSenic S.A. reported quarterly total liabilities of 32.26 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of BioSenic S.A. (2023 - 2011)

Historical Annual Total Liabilities of BioSenic S.A. (2023 - 2011)

Year Total Liabilities Total Liabilities Growth
2023 32.26 Million EUR 23.15%
2022 26.2 Million EUR -1.27%
2021 26.53 Million EUR 23.37%
2020 21.51 Million EUR 5.73%
2019 20.34 Million EUR -4.31%
2018 21.26 Million EUR -6.7%
2017 22.79 Million EUR -2.25%
2016 23.31 Million EUR 4.85%
2015 22.23 Million EUR -33.99%
2014 33.68 Million EUR 164.25%
2013 12.74 Million EUR 8.22%
2012 11.78 Million EUR 4.79%
2011 11.24 Million EUR 0.0%

Peer Total Liabilities Comparison of BioSenic S.A.

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -366.782%
ABIVAX Société Anonyme 131.05 Million EUR 75.381%
Adocia SA 31.87 Million EUR -1.236%
Aelis Farma SA 13.08 Million EUR -146.667%
Biophytis S.A. 15.84 Million EUR -103.571%
Advicenne S.A. 24.37 Million EUR -32.354%
genOway Société anonyme 14.45 Million EUR -123.133%
IntegraGen SA 5.97 Million EUR -439.55%
Medesis Pharma S.A. 6.42 Million EUR -402.071%
Neovacs S.A. 3.71 Million EUR -769.152%
NFL Biosciences SA 3.62 Million EUR -791.103%
Plant Advanced Technologies SA 6.78 Million EUR -375.705%
Quantum Genomics Société Anonyme 3.31 Million EUR -874.712%
Sensorion SA 13.22 Million EUR -143.92%
Theranexus Société Anonyme 5.01 Million EUR -543.197%
TME Pharma N.V. 2.78 Million EUR -1058.492%
Valbiotis SA 13.7 Million EUR -135.366%
TheraVet SA 1.48 Million EUR -2072.67%
Valerio Therapeutics Société anonyme 20.46 Million EUR -57.631%
argenx SE 402.79 Million EUR 91.99%
Celyad Oncology SA 9.97 Million EUR -223.351%
DBV Technologies S.A. 38.74 Million USD 16.728%
Galapagos NV 1.56 Billion EUR 97.934%
Genfit S.A. 105.92 Million EUR 69.54%
GeNeuro SA 20.13 Million EUR -60.199%
Hyloris Pharmaceuticals SA 8.61 Million EUR -274.64%
Innate Pharma S.A. 132.29 Million EUR 75.612%
Inventiva S.A. 101.59 Million EUR 68.242%
MaaT Pharma SA 22.46 Million EUR -43.619%
MedinCell S.A. 77.77 Million EUR 58.514%
Nanobiotix S.A. 95.74 Million EUR 66.3%
Onward Medical N.V. 25.69 Million EUR -25.551%
Oryzon Genomics S.A. 25.12 Million EUR -28.411%
OSE Immunotherapeutics SA 59.07 Million EUR 45.388%
Oxurion NV 19.73 Million EUR -63.478%
Pharming Group N.V. 228.28 Million EUR 85.867%
Poxel S.A. 53.9 Million EUR 40.142%
GenSight Biologics S.A. 34.72 Million EUR 7.092%
Transgene SA 26.51 Million EUR -21.673%
Financière de Tubize SA 123.65 Million EUR 73.907%
UCB SA 6.56 Billion EUR 99.508%
Valneva SE 341.14 Million EUR 90.542%
Vivoryon Therapeutics N.V. 4.54 Million EUR -609.567%